— Know what they know.
Not Investment Advice

ALMS NASDAQ

Alumis Inc. Common Stock
1W: -10.0% 1M: -14.4% 3M: -20.7% YTD: +147.4% 1Y: +354.3%
$22.02
-0.15 (-0.68%)
After Hours: $23.40 (+1.38, +6.27%)
Weekly Expected Move ±8.5%
$19 $21 $23 $25 $27
NASDAQ · Healthcare · Biotechnology · Alpha Radar Sell · Power 31 · $2.7B mcap · 84M float · 1.59% daily turnover · Short 71% of daily vol

Balance Sheet Trends

Total Assets
$412M +20.8% ▲
3Y CAGR: +56.2%
Total Liabilities
$111M +36.8% ▲
3Y CAGR: -28.6%
Shareholders Equity
$301M +15.8% ▲
Cash & Investments
$309M +7.0% ▲
3Y CAGR: +49.2%
Total Debt
$37M +20.2% ▲
3Y CAGR: +174.8%
Net Debt
-$53M +62.0% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2022FY2023FY2024FY2025
— Assets —
Cash$26M$46M$170M$90M
Short-Term Investments$67M$3M$119M$219M
Cash & ST Investments$93M$49M$288M$309M
Net Receivables$500K$722K$2M$2M
Inventory$0$0$0$0
Other Current Assets$206K$208K$762K$8M
Total Current Assets$103M$53M$306M$318M
Property, Plant & Equip.$4M$35M$34M$35M
Goodwill & Intangibles$0$0$0$51M
Long-Term Investments$0$0$0$0
Other Non-Current Assets$1M$1M$1M$8M
Total Non-Current Assets$6M$36M$35M$94M
Total Assets$108M$90M$341M$412M
— Liabilities —
Accounts Payable$2M$1M$10M$10M
Short-Term Debt$0$0$0$5M
Deferred Revenue$0$0$0$1M
Other Current Liabilities$4M$6M$8M$57M
Total Current Liabilities$13M$21M$51M$73M
Long-Term Debt$0$0$0$0
Other Non-Current Liab.$290M$377M$814K$330K
Total Non-Current Liabilities$290M$408M$30M$37M
Total Liabilities$303M$429M$81M$111M
— Equity —
Common Stock$1K$1K$4K$9K
Retained Earnings-$209M-$364M-$659M-$902M
Accumulated OCI-$127K$2K$40K$188K
Total Stockholders Equity-$195M-$339M$260M$301M
Total Liabilities & Equity$108M$90M$341M$412M
— Key Metrics —
Total Debt$2M$33M$31M$37M
Net Debt-$24M-$13M-$139M-$53M
Total Investments$67M$3M$119M$219M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms